Rxivist combines preprints from bioRxiv with data from Twitter to help you find the papers being discussed in your field. Currently indexing 70,177 bioRxiv papers from 306,444 authors.
Non-oncology drugs are a source of previously unappreciated anti-cancer activity
Steven M. Corsello,
Rohith T Nagari,
Ryan D Spangler,
Jordan G Bryan,
Andrew A Tang,
Vickie M Wang,
Samantha A Bender,
Matthew G Rees,
Nicholas J. Lyons,
James M. McFarland,
Bang T Wong,
Patrick J. O’Hearn,
John G Doench,
Jennifer A Roth,
Joshua A. Bittker,
Jesse S. Boehm,
Christopher C Mader,
Todd R. Golub
Posted 09 Aug 2019
bioRxiv DOI: 10.1101/730119
Posted 09 Aug 2019
Anti-cancer uses of non-oncology drugs have been found on occasion, but such discoveries have been serendipitous and rare. We sought to create a public resource containing the growth inhibitory activity of 4,518 drugs tested across 578 human cancer cell lines. To accomplish this, we used PRISM, which involves drug treatment of molecularly barcoded cell lines in pools. Relative barcode abundance following treatment thus reflects viability of each cell line. We found that an unexpectedly large number of non-oncology drugs selectively inhibited subsets of cancer cell lines. Moreover, the killing activity of the majority of these drugs was predictable based on the molecular features of the cell lines. Follow-up of several of these compounds revealed novel mechanisms. For example, compounds that kill by inducing PDE3A-SLFN12 complex formation; vanadium-containing compounds whose killing is dependent on the sulfate transporter SLC26A2; the alcohol dependence drug disulfiram, which kills cells with low expression of metallothioneins; and the anti-inflammatory drug tepoxalin, whose killing is dependent on high expression of the multi-drug resistance gene ABCB1. These results illustrate the potential of the PRISM drug repurposing resource as a starting point for new oncology therapeutic development. The resource is available at https://depmap.org.
- Downloaded 2,491 times
- Download rankings, all-time:
- Site-wide: 1,730 out of 70,177
- In cancer biology: 46 out of 2,385
- Year to date:
- Site-wide: 781 out of 70,177
- Since beginning of last month:
- Site-wide: 371 out of 70,177
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!